Membrane drug transporters in cancer: From chemoresistance mechanism to therapeutic strategies
Authors:
- 23 January 2025
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1880 (2) , 189272
Abstract
No abstract availableKeywords
This publication has 236 references indexed in Scilit:
- Modulation of Metal Homeostasis for Cancer TherapyChempluschem, 2024
- Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter ConsortiumClinical Pharmacology & Therapeutics, 2022
- Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer MetastasisClinical Pharmacology & Therapeutics, 2022
- Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer‐bearing mice and patientsCancer Medicine, 2020
- Role of three‐dimensional matrix stiffness in regulating the chemoresistance of hepatocellular carcinoma cellsBiotechnology and Applied Biochemistry, 2014
- Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)ChemMedChem, 2010
- Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†Hepatology, 2009
- A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX‐710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancerCancer, 2007
- Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)Cancer, 2006
- Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factorsHepatology, 2004